-transparent.png){kind=logo}
Benzaldehyde, in the form of 4,6-benzylidene-alpha-D-glucose (BG), was given iv at a daily dose of 720-1800 mg/m2 to 65 patients with inoperable carcinoma in the advanced stages. The overall objective response rate was 55%; seven patients achieved complete response, 29 achieved partial response, 24 remained stable, and five showed progressive disease. Response was seen in various cell types. Prolongation of survival was apparent for the patients. Toxic reactions were not observed during long-term injection with BG.
Related Publications
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
January 1980,
Cancer treatment reports,
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
November 2023,
Journal of fungi (Basel, Switzerland),
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
January 1992,
Yao xue xue bao = Acta pharmaceutica Sinica,
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
March 1960,
Science (New York, N.Y.),
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
January 2014,
Asian Pacific journal of cancer prevention : APJCP,
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
March 1998,
Anti-cancer drugs,
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
January 1991,
Cancer chemotherapy and pharmacology,
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
October 2016,
Journal of medicinal chemistry,
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
October 1999,
Anti-cancer drugs,
M Kochi, and
N Isono, and
M Niwayama, and
K Shirakabe
October 2012,
The American journal of the medical sciences,
